Lovastatin Tablet
Product Images NDC 43063-983

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 43063-983). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063983 Label (43063983)

Lovastatin USP 20 mg tablet bottle label by PD-Rx Pharmaceuticals, Inc. The label shows the NDC 43063-983-30, bottle count of 30 tablets, and includes warnings to keep out of reach of children. It features reorder number 110807, lot J19D22, and expiration 10/2021. The label has manufacturer details and barcodes.*

FDA Label Image

Structural Formula (Lov00 0004 01)

Chemical structure of lovastatin, showing its molecular framework with rings and functional groups consistent with its known statin class configuration.*

FDA Label Image

Table I (Lov00 0004 02)

Table presenting the effect of other drugs or grapefruit juice on lovastatin exposure when co-administered, showing number of subjects, dosing of coadministered drug or grapefruit juice, dosing of lovastatin, and the AUC ratio comparing exposure with and without coadministered substances.*

FDA Label Image

Figure 1 (Lov00 0004 03)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' shows the proportion of participants without event over 6 years of follow-up. Two lines compare Lovastatin and placebo groups, indicating a 37% risk reduction with Lovastatin (p<0.001). The y-axis ranges from 0.90 to 1.0, and the x-axis marks years from 0 to 6.*

FDA Label Image

Table Vii (Lov00 0005 04)

A data table titled 'Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis' lists interacting agents such as strong CYP3A4 inhibitors, HIV protease inhibitors, gemfibrozil, cyclosporine, danazol, diltiazem, dronedarone, verapamil, amiodarone, and grapefruit juice, along with prescribing recommendations related to lovastatin dosage limits and contraindications.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.